Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ross

Showing results (1691-1700 of 1,804) with videos related to

Pageof 181
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2012
Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcomePaula J Hurley, Luigi Marchionni, Brian W Simons, et al.
Blood|April 2, 2008
High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) studyChristian Langer, Michael D Radmacher, Amy S Ruppert, et al.
Neuron|June 12, 2003
Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilizationFumiaki Saito, Steven A Moore, Rita Barresi, et al.
Prostate Cancer and Prostatic Diseases|May 20, 2015
High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancerS G Zhao, W C Jackson, V Kothari, et al.
The Journal of Urology|May 21, 2019
African American Specific Gene Panel Predictive of Poor Prostate Cancer OutcomeMichelle I Echevarria, Shivanshu Awasthi, Chia-Ho Cheng, et al.
The Prostate|May 23, 2025
Germline Testing for Prostate Cancer Patients: Evidence-Based Evaluation of Genes Recommended by NCCN GuidelinesJianfeng Xu, Jim Lu, Marta Gielzak, et al.
The Journal of Urology|March 23, 2026
Clinical and Reader Associated Correlates of Clinically Significant MRI-Invisible Prostate Cancer based on Negative MRIMarina Schnauss, Nicole Handa, Ramin Nateghi, et al.
The Journal of Urology|August 30, 2016
Molecular Analysis of Low Grade Prostate Cancer Using a Genomic Classifier of Metastatic PotentialEric A Klein, María Santiago-Jiménez, Kasra Yousefi, et al.
The Journal of Urology|July 25, 2017
Prostate Specific Membrane Antigen Targeted <sup>18</sup>F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center StudyMichael A Gorin, Steven P Rowe, Hiten D Patel, et al.
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
The Impact of Malnutrition on Host Responses to Severe Infection in Adults: A Multicenter Analysis from UgandaGabriel Conte Cortez Martins, Julius J Lutwama, Nicholas Owor, et al.
Pageof 181

Showing results (1691-1700 of 1,804) with videos related to

Sort By:
Pageof 181
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2012
Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcomePaula J Hurley, Luigi Marchionni, Brian W Simons, et al.
Blood|April 2, 2008
High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) studyChristian Langer, Michael D Radmacher, Amy S Ruppert, et al.
Neuron|June 12, 2003
Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilizationFumiaki Saito, Steven A Moore, Rita Barresi, et al.
Prostate Cancer and Prostatic Diseases|May 20, 2015
High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancerS G Zhao, W C Jackson, V Kothari, et al.
The Journal of Urology|May 21, 2019
African American Specific Gene Panel Predictive of Poor Prostate Cancer OutcomeMichelle I Echevarria, Shivanshu Awasthi, Chia-Ho Cheng, et al.
The Prostate|May 23, 2025
Germline Testing for Prostate Cancer Patients: Evidence-Based Evaluation of Genes Recommended by NCCN GuidelinesJianfeng Xu, Jim Lu, Marta Gielzak, et al.
The Journal of Urology|March 23, 2026
Clinical and Reader Associated Correlates of Clinically Significant MRI-Invisible Prostate Cancer based on Negative MRIMarina Schnauss, Nicole Handa, Ramin Nateghi, et al.
The Journal of Urology|August 30, 2016
Molecular Analysis of Low Grade Prostate Cancer Using a Genomic Classifier of Metastatic PotentialEric A Klein, María Santiago-Jiménez, Kasra Yousefi, et al.
The Journal of Urology|July 25, 2017
Prostate Specific Membrane Antigen Targeted <sup>18</sup>F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center StudyMichael A Gorin, Steven P Rowe, Hiten D Patel, et al.
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
The Impact of Malnutrition on Host Responses to Severe Infection in Adults: A Multicenter Analysis from UgandaGabriel Conte Cortez Martins, Julius J Lutwama, Nicholas Owor, et al.
Pageof 181